← Back to headlines
Pfizer and Astellas Pharma Announce Positive Results for PADCEVTM Clinical Trial
Pfizer Inc. and Astellas Pharma have announced positive results from their Phase 3 EV-304 clinical trial for the drug PADCEVTM.
1 Mar, 09:27 — 1 Mar, 09:27
Sources
Showing 1 of 1 sources
